All In MedTech

Company

Endologix

Funding, FDA decisions, device trials, adverse event reports and recalls filed under this company's name in public data. Records are matched by name, so a subsidiary or an unusual spelling can be missed.

Last checked: Nov 20, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations

This company is not on our public-company list, so only this exact name is matched. Naming a company here is not a recommendation of it or of any security.

Financing

From SEC filings.

We found no SEC financing filings under the name Endologix, so its financing is unknown here. That is common for companies based outside the US, for subsidiaries of larger companies, and for companies funded by founders, grants or customers. A company that changed its name can also be missed.

Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys.

Investors

5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.

No 5%+ shareholder filings or SBIR grants found under the name Endologix.

Latest FDA decisions

Search the Clearance Tracker

Device trials

Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.

Open in the Trial Radar
  • NCT05064540 · 450 participants (planned) · Start Sep 20, 2021 · Primary completion Mar 2032

    Device: Alto Abdominal Stent Graft System; FDA Approved EVAR AAA Graft Systems · For: AAA; AAA - Abdominal Aortic Aneurysm

    Sites: Huntsville, Alabama; Tucson, Arizona; Fayetteville, Arkansas · 29 sites in all

  • NCT04130737 · 188 participants · Start Aug 13, 2018 · Primary completion Jan 6, 2023

    Device: TORUS Stent Graft System · For: Peripheral Arterial Disease

    Sites: Mesa, Arizona; Phoenix, Arizona; Yuma, Arizona · 32 sites in all

  • NCT02996396 · 48 participants · Start Nov 2016 · Primary completion Apr 25, 2023

    Device: Nellix Endovascular Aneurysm Sealing System (Nellix®-System) · For: Abdominal Aortic Aneurysm

    Sites: Augsburg, Germany; Bonn, Germany; Cologne, Germany · 10 sites in all

21 more trials with a free account

Reports received

313

Received Nov 1, 2025 to Nov 20, 2026. Includes 1 of another or unstated type.

Malfunction reports

13

4.2% of reports

Injury reports

283

90% of reports

Death reports

16

5.1% of reports

Adverse event reports received per month

Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.

Search the MAUDE Monitor
  • Malfunction
  • Injury
  • Death
  • Other
View as table
MonthMalfunctionInjuryDeathOther
Dec 2324110
Jan 2422200
Feb 2412620
Mar 2403900
Apr 2402230
May 2403900
Jun 2422710
Jul 2402810
Aug 2422600
Sep 2411700
Oct 2401710
Nov 2412410
Dec 2402810
Jan 2512200
Feb 2501810
Mar 2502300
Apr 2513000
May 25037140
Jun 2521930
Jul 2502500
Aug 2513110
Sep 2501910
Oct 2512200
Nov 2501600
Dec 2512610
Jan 2601010
Feb 2621620
Mar 2612610
Apr 2642410
May 2631800
Jun 2602740
Jul 2613210
Aug 2601821
Sep 2612420
Oct 2604610
Nov 260000

Device types named most often

Last 12 months, by FDA product code. A company that sells more gets more reports.

Brand names named most often

Last 12 months, as written on the reports. One product can appear under several spellings.

7 more in this ranking with a free account

Recent recalls

From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

23 more recall records with a free account

Back to all tools

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.